Evommune Inc
EVMN22.180USD
-1.350-5.70%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
667.12MMarket Cap
LossP/E TTM
More Details of Company
Evommune Inc Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Evommune Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-0.52%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Dr. Jeegar P. Patel, Ph.D.
Dr. Jeegar P. Patel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Francois Beaubien, Ph.D.
Dr. Francois Beaubien, Ph.D.
Director
Director
--
--
Dr. David Eric Cohen, M.D.
Dr. David Eric Cohen, M.D.
Independent Director
Independent Director
--
--
Dr. Derek DiRocco, Ph.D.
Dr. Derek DiRocco, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
284.94K
-0.52%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Feb 25
Updated: Wed, Feb 25
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
Other
51.31%
Shareholders
Shareholders
Proportion
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
Other
51.31%
Shareholder Types
Shareholders
Proportion
Venture Capital
36.77%
Private Equity
19.95%
Investment Advisor/Hedge Fund
13.92%
Investment Advisor
12.27%
Hedge Fund
7.84%
Individual Investor
4.19%
Corporation
3.07%
Research Firm
0.18%
Bank and Trust
0.09%
Other
1.71%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
4
12.40M
0.00%
--
2025Q4
14
14.63M
46.41%
+14.63M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
EQT Life Sciences
4.93M
15.64%
+4.93M
--
Nov 07, 2025
RA Capital Management, LP
2.21M
7.01%
+2.21M
--
Nov 06, 2025
Pivotal Bioventure Partners Investment Advisor LLC
3.37M
10.68%
+3.37M
--
Nov 06, 2025
Andera Partners S.A.S.
1.90M
6.02%
+1.90M
--
Nov 07, 2025
B Capital Group Management LP
1.10M
3.5%
+1.10M
--
Nov 06, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
